• P. S. Bhandare Department of Pharmacology, GIPER, Limb, Satara: 415015, India
  • A. V Yadav Principal, GIPER, Limb, Satara: 415015, India


Suspensions may be defined as preparations containing finely divided drug particles (the suspensoid) distributed somewhat uniformly throughout a vehicle with or without stabilizers and other additives in which drug exhibits a minimum degree of solubility hence conventional oral suspension can be administered immediately (ready to use form) and not requiring reconstitution at the time of dispensing are simply designated as “Oral Suspension”.

There is an important category of suspension that are available as dry powders intended for suspension in liquid vehicles. These are dry mixtures containing the drug and suitable suspending and dispersing agents to be diluted and agitated with a specific quantity of vehicle, most often purified water. Drugs that are instable if maintained for extended periods in the presence of aqueous vehicle (eg., many antibiotic drugs) are frequently supplied as dry powder mixtures for reconstitution at the time of dispensing. This type of preparation is designated in the USP by a title “for Oral Suspension”. The reconstituted system is the formulation of choice when the drug stability is a major concern. After reconstitution, these systems have a short but acceptable life if stored at refrigerator temperatures. Reconstitutable oral systems show the adequate chemical stability of the drug during shelf life, avoids the physical stability problems related to solubility, pH and incompatibilities with other ingredients and also reduce the weight of the final product because the aqueous vehicle is absent and consequently the transportation expenses may be reduced.

Dry syrup form of the drug is also useful in case of bioavailability as it has high bioavailability rather than tablets and capsules as it disintegrates in water outside of the oral cavity and directly the suspension is gone through the gastrointestinal tract. So the suspension easily absorbs in the GIT.

A number of commercial and official preparations are available as dry powder mixtures. The present review gives an account of the excipients used, methods of preparation of dry syrups along with their evaluations, their packaging, examples of research articles, few marketed preparations.

Keywords: Dry suspension, Dry syrup, Reconstitutable oral suspension. Patient compliance and stability of formulation


1. Howard CA. Introduction of pharmaceutical dosage forms; Lea and Febiger, Philadelphia; 1981. p. 139-66.
2. Ofner CM, Schnaare RL, Schwartz JB. Reconstitutable oral suspension”. Lieberman HA, Rieger MM, Banker GS. Pharmaceutical dosage forms and disperse system; Vol. 2. 2nd Edition. (New York: Marcel dekkar Inc) NJ; 1984. p. 243-59.
3. Lieberman HA, Rieger MM, Banker GS. Pharmaceutical dosage forms and disperse system. Vol. 2. 2nd Edition. (New York: Marcel dekkar Inc.); 1994. p. 149-77.
4. Casilda Bardeskar, Racheal Geeverghese. Reconstituitable oral suspensions (Dry Syrups): an overview. World J Pharm Res 2015;4:462-84.
5. Parmar Pratik, MR Patel, KR Patel, NM Patel. “A review on taste masking pediatric dry syrup”. Int J Univers Pharm Bio Sci 2013;2:2319-8141.
6. European Medicines Agency ICH Topic Q 6 A Specifications: test procedures and acceptance criteria for new drug substances and new drug products: Chemical Substances; 2000.
7. Vijay Kumar Singh, Vikash Kumar Mishra, Jayant Kumar Maurya. Formulation and evaluation of cephalexin monohydrate re-constitutional oral suspension with piperine and their antibacterial activity. World J Pharm Res 2014; 3:821-31.
8. Indian pharmacopoeia. Vol. II; 2014. p. 952-1057.
9. Umut Can Oz, Burcu Devrim, Asuman Bozk?r, Kandemir Canefe. Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery. J Microencapsulation 2015;32:317-28.
10. Mine Orlu-Gul, Giacomo Fisco, Dipesh Parmar, Hardyal Gill, Catherine Tuleu. A new reconstitutable oral paediatric hydrocortisone solution containing hydroxypropyl-?-cyclodextrin. Drug Dev Ind Pharm 2013;39:1028-36.
11. www.google.com [Last accessed on 10 Sep 2016]
1249 Views | 11628 Downloads
How to Cite
Bhandare, P. S., and A. V. Yadav. “A REVIEW ON ‘DRY SYRUPS FOR PAEDIATRICS’”. International Journal of Current Pharmaceutical Research, Vol. 9, no. 1, Dec. 2016, pp. 25-31, doi:10.22159/ijcpr.2017v9i1.16789.
Review Article(s)